CH14.18 1021 Antibody and IL2 After Haplo SCT in Children With Relapsed Neuroblastoma
NCT02258815
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
35
Enrollment
OTHER
Sponsor class
Conditions
Neuroblastoma Recurrent
Interventions
DRUG:
ch14.18/CHO
Sponsor
University Children's Hospital Tuebingen